Q1 2021 13F Holders as of 3/31/2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
50M
-
Number of holders
-
114
-
Total 13F shares, excl. options
-
23.5M
-
Shares change
-
+8.93M
-
Total reported value, excl. options
-
$604M
-
Value change
-
+$242M
-
Put/Call ratio
-
2.19
-
Number of buys
-
94
-
Number of sells
-
-30
-
Price
-
$25.69
Significant Holders of KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (KALV) as of Q1 2021
139 filings reported holding KALV - KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share as of Q1 2021.
KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (KALV) has 114 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 23.5M shares
of 50M outstanding shares and own 47.01% of the company stock.
Largest 10 shareholders include Vivo Capital, LLC (1.86M shares), BlackRock Inc. (1.56M shares), WELLINGTON MANAGEMENT GROUP LLP (1.51M shares), EVENTIDE ASSET MANAGEMENT, LLC (1.37M shares), FMR LLC (1.35M shares), FRANKLIN RESOURCES INC (1.29M shares), JANUS HENDERSON GROUP PLC (1.13M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (1.02M shares), Polar Capital Holdings Plc (1.01M shares), and SUVRETTA CAPITAL MANAGEMENT, LLC (960K shares).
This table shows the top 114 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.